NF1 and breast cancer: Although NF1 is considered a “driver gene” in the pathogenesis of BC also in the general population, and NF1 haploinsufficiency is a known predictive factor of poor clinical outcome both in sporadic, and NF1-related BC, the exact mechanisms underlying the increased risk of developing BC in women with NF1 are still not clarified [13].